Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein phosphatase 4 regulatory subunit 3C (PPP4R3C) is a non-catalytic regulatory protein that forms part of the serine/threonine-protein phosphatase 4 complex. It is predicted to act as an **activator** of protein phosphatase activity, facilitating the function of the catalytic subunit PPP4C. PPP4R3C has been implicated in the regulation of DNA damage response, particularly double-strand break repair. While its precise physiological and pathological roles are still being characterized, PPP4R3C does not act as a direct therapeutic target, enzyme, receptor, or transporter. Instead, it modulates the functions of the protein phosphatase 4 complex within the nucleoplasm[1][2][3][4][6][7].\n\n**Notes:** \n- This gene is sometimes annotated as a pseudogene and is not considered a direct drug target. There are currently no known drugs, disease associations, or safety concerns specifically linked to PPP4R3C[6][3][4][7].\n- Some aliases (such as "suppressor of mek1 pseudogene") refer to potential pseudogene status but sequence analysis and functional annotation indicate a protein-coding regulatory subunit in mammals[3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein phosphatase 4 regulatory subunit 3C (PPP4R3C).